Neurontin Whistleblower Alleges Sham Research Arrangements, Atty. Says
Executive Summary
The whistleblower suit against Parke-Davis includes allegations that the company ran sham research programs to encourage use of its products, Sidley Austin Brown & Wood partner Scott Bass told a recent Drug Information Association meeting on marketing and compliance in New York City
You may also be interested in...
Schering-Plough Faces Criminal Case; Off-Label Promotion May Be One Count
A criminal investigation of Schering-Plough's marketing practices includes off-label promotion, the company disclosed May 30
Schering-Plough Faces Criminal Case; Off-Label Promotion May Be One Count
A criminal investigation of Schering-Plough's marketing practices includes off-label promotion, the company disclosed May 30
Serostim Off-Label Use Under Scrutiny; Prosecutor Looks At Job Descriptions
The Boston U.S. Attorney's Office may be looking at employee job descriptions or performance criteria in its investigations of off-label promotion